Compounds > clindamycin

clindamycin and Graft vs Host Disease

clindamycin has been researched along with Graft vs Host Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, Y; Hino, M; Inaba, A; Inoue, A; Koh, H; Nakamae, H; Nakane, T; Nakashima, Y; Nanno, S; Nishimoto, M; Okamura, H; Shimono, T1
Arana, C; Coughlin, LA; Davies, SM; Greenberg, DE; Kim, J; Kim, M; Koh, AY; Savani, MR; Simms-Waldrip, TR; Sunkersett, G; Xie, Y; Zhan, X1
Brinkman, K; Debast, S; Hiel, J; Ooyman, F; Raemaekers, J; Sauerwein, R1

Other Studies

3 other study(ies) available for clindamycin and Graft vs Host Disease

ArticleYear
Cerebral toxoplasmosis after umbilical cord blood transplantation diagnosed by the detection of anti-toxoplasma specific IgM antibody in cerebrospinal fluid.
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:4

    Topics: Antibodies, Protozoan; Biomarkers; Clindamycin; Cord Blood Stem Cell Transplantation; Early Diagnosis; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunoglobulin M; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Tacrolimus; Toxoplasma; Toxoplasmosis, Cerebral; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination

2014
Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2017, Volume: 23, Issue:5

    Topics: Adolescent; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Child; Child, Preschool; Clindamycin; Clostridium; Gastrointestinal Microbiome; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Mice; Pilot Projects

2017
Toxoplasma retinitis/encephalitis 9 months after allogeneic bone marrow transplantation.
    Bone marrow transplantation, 1998, Volume: 21, Issue:6

    Topics: Adult; Anti-Infective Agents; Bone Marrow Transplantation; Clindamycin; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Pyrimethamine; Sulfadiazine; Toxoplasmosis, Cerebral; Toxoplasmosis, Ocular

1998